These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 21729849)

  • 41. Impact of pharmacy-supported interventions on proportion of patients receiving non-indicated acid suppressive therapy upon discharge: A systematic review and meta-analysis.
    Singh-Franco D; Mastropietro DR; Metzner M; Dressler MD; Fares A; Johnson M; De La Rosa D; Wolowich WR
    PLoS One; 2020; 15(12):e0243134. PubMed ID: 33270710
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Educating junior doctors and pharmacists to reduce discharge prescribing of opioids for surgical patients: a cluster randomised controlled trial.
    Hopkins RE; Bui T; Konstantatos AH; Arnold C; Magliano DJ; Liew D; Dooley MJ
    Med J Aust; 2020 Nov; 213(9):417-423. PubMed ID: 33037644
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Impact of A Collaborative Strategy to Reduce the Inappropriate Use of Acid Suppressive Therapy in Non-Intensive Care Unit Patients.
    Belfield KD; Kuyumjian AG; Teran R; Amadi M; Blatt M; Bicking K
    Ann Pharmacother; 2017 Jul; 51(7):577-583. PubMed ID: 28622739
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Community pharmacists' evaluation of potentially inappropriate prescribing in older community-dwelling patients with polypharmacy: observational research based on the GheOP³S tool.
    Tommelein E; Mehuys E; Van Tongelen I; Petrovic M; Somers A; Colin P; Demarche S; Van Hees T; Christiaens T; Boussery K
    J Public Health (Oxf); 2017 Sep; 39(3):583-592. PubMed ID: 27698269
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Drug-use review program for concurrent histamine H2-receptor antagonist-sucralfate therapy.
    Kane MP; Briceland LL; Garris RE; Favreau BN
    Am J Hosp Pharm; 1990 Sep; 47(9):2007-10. PubMed ID: 1977317
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Impacting cost and appropriateness of stress ulcer prophylaxis at a university medical center.
    Erstad BL; Camamo JM; Miller MJ; Webber AM; Fortune J
    Crit Care Med; 1997 Oct; 25(10):1678-84. PubMed ID: 9377882
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Acid-suppressive medication use and the risk for hospital-acquired pneumonia.
    Herzig SJ; Howell MD; Ngo LH; Marcantonio ER
    JAMA; 2009 May; 301(20):2120-8. PubMed ID: 19470989
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Identification of inappropriate prescribing in geriatrics at a Veterans Affairs hospital using STOPP/START screening tools.
    Pyszka LL; Seys Ranola TM; Milhans SM
    Consult Pharm; 2010 Jun; 25(6):365-73. PubMed ID: 20534407
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Impact of clinical pharmacist engagement in ward teams on the number of drug-related readmissions among older patients with dementia or cognitive impairment: An economic evaluation.
    Sjölander M; Lindholm L; Pfister B; Jonsson J; Schneede J; Lövheim H; Gustafsson M
    Res Social Adm Pharm; 2019 Mar; 15(3):287-291. PubMed ID: 29778344
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Impact of medication reviews on inappropriate prescribing in aged care.
    Koria LG; Zaidi TS; Peterson G; Nishtala P; Hannah PJ; Castelino R
    Curr Med Res Opin; 2018 May; 34(5):833-838. PubMed ID: 29301404
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Impact of pharmacists' interventions and simvastatin dose restrictions.
    Shoulders BR; Franks AS; Barlow PB; Williams JD; Farland MZ
    Ann Pharmacother; 2014 Jan; 48(1):54-61. PubMed ID: 24259645
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Impact of pharmacist interventions on clinical outcome and cost avoidance in a university teaching hospital.
    Jourdan JP; Muzard A; Goyer I; Ollivier Y; Oulkhouir Y; Henri P; Parienti JJ; Breuil C
    Int J Clin Pharm; 2018 Dec; 40(6):1474-1481. PubMed ID: 30367375
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pharmacist review of high-risk haematology outpatients to improve appropriateness of antifungal prophylaxis.
    Reslan Z; Lindsay J; Kerridge I; Gellatly R
    Int J Clin Pharm; 2020 Dec; 42(6):1412-1418. PubMed ID: 33009604
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Proton bomb inhibitors: a study of the prescription in a functional recovery unit].
    López-Dóriga Bonnardeaux P; Neira Álvarez M; Mansilla Laguía S
    Rev Esp Geriatr Gerontol; 2013; 48(6):269-71. PubMed ID: 24099902
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Potentially inappropriate prescribing in older adults with advanced chronic kidney disease.
    Molnar AO; Bota S; Jeyakumar N; McArthur E; Battistella M; Garg AX; Sood MM; Brimble KS
    PLoS One; 2020; 15(8):e0237868. PubMed ID: 32818951
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Reduction of inappropriate exit prescriptions for proton pump inhibitors: A before-after study using education paired with a web-based quality-improvement tool.
    McDonald EG; Jones J; Green L; Jayaraman D; Lee TC
    J Hosp Med; 2015 May; 10(5):281-6. PubMed ID: 25708942
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Characteristic of drug-related problems and pharmacists' interventions in a stroke unit in Thailand.
    Semcharoen K; Supornpun S; Nathisuwan S; Kongwatcharapong J
    Int J Clin Pharm; 2019 Aug; 41(4):880-887. PubMed ID: 31054061
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of a Pharmacist-Driven Medication Management Intervention Among Older Adults in an Inpatient Setting.
    Alosaimy S; Vaidya A; Day K; Stern G
    Drugs Aging; 2019 Apr; 36(4):371-378. PubMed ID: 30671871
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The use of proton pump inhibitors in an Italian hospital: focus on oncologic and critical non-ICU patients.
    Meli M; Raffa MP; Malta R; Morreale I; Aprea L; D'Alessandro N
    Int J Clin Pharm; 2015 Dec; 37(6):1152-61. PubMed ID: 26319396
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The impact of a pharmacist on post-take ward round prescribing and medication appropriateness.
    Bullock B; Donovan P; Mitchell C; Whitty JA; Coombes I
    Int J Clin Pharm; 2019 Feb; 41(1):65-73. PubMed ID: 30610543
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.